EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Donepezil Derivatives as Potential Dual AChE/BChE Inhibitors: Fragment-Based Design, AI-Assisted Retrosynthesis, and In Silico Evaluation

Marko Antonijević, Jelena Đorović Jovanović, Marijana Stanojević Pirković, Miona Glišić, Ana Antonijević, Svetlana Jeremić

Compounds · 24.07.2026 · 6 (3) · 45

DOI: 10.3390/compounds6030045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Compounds, online erschienen am 24.07.2026. Verfasst von Marko Antonijević und 5 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development, and Innovation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a complex neurodegenerative condition marked by a gradual decline in cognitive abilities, a reduction in acetylcholine (ACh) levels, and the accumulation of β-amyloid (Aβ) plaques. In a healthy brain, approximately 80% of ACh is broken down by acetylcholinesterase (AChE). Meanwhile, butyrylcholinesterase (BChE) serves a supportive function, gaining significance as AChE activity diminishes during the progression of Alzheimer’s disease. Modern therapeutic approaches focus on creating dual inhibitors of AChE and BChE that also aim to diminish Aβ-amyloidogenesis through interactions with the peripheral anionic site (PAS). This study combined fragment-based molecular design (CReM), AI-assisted retrosynthetic feasibility assessment, and in silico evaluation (docking, molecular dynamics, and ADMET profiling) to identify novel Donepezil derivatives as potential dual AChE/BChE inhibitors. A series of 10,000 derivatives were developed through computational methods and carefully assessed based on stringent drug-likeness, synthetic accessibility, and medicinal chemistry standards. This was succeeded by comprehensive ADMET profiling. Nine candidates were identified with predicted CNS pharmacokinetics, adequate toxicological profiles and reduced cytochrome P450 liabilities. Molecular docking yielded improved predicted binding affinities relative to Donepezil. Several derivatives, particularly D4 and D5, showed dual-site binding poses spanning both the catalytic gorge and the PAS. MD simulations indicated the stability of these poses over 100 ns. These computational results suggest that the proposed derivatives may preserve or improve upon Donepezil’s pharmacokinetic profile while offering potentially balanced AChE/BChE inhibition and anti-amyloidogenic activity, pending experimental validation.

Förderung

  • Ministry of Science, Technological Development, and Innovation

Zitieren

APA

Antonijević, M., Jovanović, J. Đ., Pirković, M. S., Glišić, M., Antonijević, A., & Jeremić, S. (2026). Donepezil Derivatives as Potential Dual AChE/BChE Inhibitors: Fragment-Based Design, AI-Assisted Retrosynthesis, and In Silico Evaluation. Compounds, 6(3), 45. https://doi.org/10.3390/compounds6030045

Vancouver

Antonijević M, Jovanović JĐ, Pirković MS, Glišić M, Antonijević A, Jeremić S. Donepezil Derivatives as Potential Dual AChE/BChE Inhibitors: Fragment-Based Design, AI-Assisted Retrosynthesis, and In Silico Evaluation. Compounds. 2026;6(3):45. doi:10.3390/compounds6030045

BibTeX
@article{Antonijevi2026,
  author = {Antonijević, Marko and Jovanović, Jelena Đorović and Pirković, Marijana Stanojević and Glišić, Miona and Antonijević, Ana and Jeremić, Svetlana},
  title = {Donepezil Derivatives as Potential Dual AChE/BChE Inhibitors: Fragment-Based Design, AI-Assisted Retrosynthesis, and In Silico Evaluation},
  journal = {Compounds},
  year = {2026},
  volume = {6},
  number = {3},
  pages = {45},
  doi = {10.3390/compounds6030045}
}
Kostenlos starten →